nodes	percent_of_prediction	percent_of_DWPC	metapath
Loperamide—POMC—blood plasma—abdominal aortic aneurysm	0.0671	0.164	CbGeAlD
Loperamide—POMC—connective tissue—abdominal aortic aneurysm	0.0357	0.0872	CbGeAlD
Loperamide—POMC—kidney—abdominal aortic aneurysm	0.0304	0.0742	CbGeAlD
Loperamide—CALM2—artery—abdominal aortic aneurysm	0.0244	0.0596	CbGeAlD
Loperamide—CALM1—artery—abdominal aortic aneurysm	0.0243	0.0593	CbGeAlD
Loperamide—POMC—spinal cord—abdominal aortic aneurysm	0.0237	0.0578	CbGeAlD
Loperamide—CALM2—blood plasma—abdominal aortic aneurysm	0.0183	0.0447	CbGeAlD
Loperamide—CALM1—blood plasma—abdominal aortic aneurysm	0.0183	0.0445	CbGeAlD
Loperamide—OPRD1—kidney—abdominal aortic aneurysm	0.0168	0.041	CbGeAlD
Loperamide—CYP2C8—blood plasma—abdominal aortic aneurysm	0.0152	0.0371	CbGeAlD
Loperamide—CYP2B6—blood plasma—abdominal aortic aneurysm	0.0136	0.0333	CbGeAlD
Loperamide—CYP3A4—blood plasma—abdominal aortic aneurysm	0.0103	0.0251	CbGeAlD
Loperamide—CYP2D6—blood plasma—abdominal aortic aneurysm	0.0101	0.0247	CbGeAlD
Loperamide—CALM2—connective tissue—abdominal aortic aneurysm	0.00976	0.0238	CbGeAlD
Loperamide—CALM1—connective tissue—abdominal aortic aneurysm	0.00972	0.0237	CbGeAlD
Loperamide—OPRM1—spinal cord—abdominal aortic aneurysm	0.00892	0.0218	CbGeAlD
Loperamide—CALM2—kidney—abdominal aortic aneurysm	0.00831	0.0203	CbGeAlD
Loperamide—CALM1—kidney—abdominal aortic aneurysm	0.00827	0.0202	CbGeAlD
Loperamide—CALM3—spinal cord—abdominal aortic aneurysm	0.00824	0.0201	CbGeAlD
Loperamide—ABCB1—blood plasma—abdominal aortic aneurysm	0.00729	0.0178	CbGeAlD
Loperamide—CYP2C8—kidney—abdominal aortic aneurysm	0.00689	0.0168	CbGeAlD
Loperamide—CALM2—spinal cord—abdominal aortic aneurysm	0.00647	0.0158	CbGeAlD
Loperamide—CALM1—spinal cord—abdominal aortic aneurysm	0.00644	0.0157	CbGeAlD
Loperamide—CYP2B6—kidney—abdominal aortic aneurysm	0.00618	0.0151	CbGeAlD
Loperamide—CYP3A4—kidney—abdominal aortic aneurysm	0.00467	0.0114	CbGeAlD
Loperamide—CYP2D6—kidney—abdominal aortic aneurysm	0.00459	0.0112	CbGeAlD
Loperamide—ABCB1—kidney—abdominal aortic aneurysm	0.0033	0.00806	CbGeAlD
Loperamide—ABCB1—spinal cord—abdominal aortic aneurysm	0.00257	0.00627	CbGeAlD
Loperamide—OPRD1—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.00111	0.00189	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00109	0.00185	CbGpPWpGaD
Loperamide—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.00108	0.00184	CbGpPWpGaD
Loperamide—CALM2—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—abdominal aortic aneurysm	0.00108	0.00183	CbGpPWpGaD
Loperamide—CALM1—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—abdominal aortic aneurysm	0.00108	0.00183	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.00108	0.00183	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—P2RY12—abdominal aortic aneurysm	0.00107	0.00181	CbGpPWpGaD
Loperamide—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.00106	0.00179	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—P2RY12—abdominal aortic aneurysm	0.00103	0.00175	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—P2RY12—abdominal aortic aneurysm	0.00103	0.00175	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—SELL—abdominal aortic aneurysm	0.00102	0.00174	CbGpPWpGaD
Loperamide—POMC—Metabolism—AGT—abdominal aortic aneurysm	0.00102	0.00172	CbGpPWpGaD
Loperamide—POMC—Metabolism—APOE—abdominal aortic aneurysm	0.000996	0.00169	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—SELL—abdominal aortic aneurysm	0.00099	0.00168	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—SELL—abdominal aortic aneurysm	0.00099	0.00168	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.000989	0.00168	CbGpPWpGaD
Loperamide—OPRK1—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.000976	0.00165	CbGpPWpGaD
Loperamide—OPRD1—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.000917	0.00155	CbGpPWpGaD
Loperamide—OPRD1—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.000894	0.00152	CbGpPWpGaD
Loperamide—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.000892	0.00151	CbGpPWpGaD
Loperamide—CACNA1A—Metabolism—AGT—abdominal aortic aneurysm	0.000879	0.00149	CbGpPWpGaD
Loperamide—CACNA1A—Metabolism—APOE—abdominal aortic aneurysm	0.000861	0.00146	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—AGT—abdominal aortic aneurysm	0.00085	0.00144	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000842	0.00143	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000833	0.00141	CbGpPWpGaD
Loperamide—OPRM1—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.000825	0.0014	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.000812	0.00138	CbGpPWpGaD
Loperamide—OPRK1—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.000804	0.00136	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000788	0.00134	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.000784	0.00133	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000739	0.00125	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.000724	0.00123	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.000712	0.00121	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.0007	0.00119	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—NCF1—abdominal aortic aneurysm	0.000699	0.00118	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000691	0.00117	CbGpPWpGaD
Loperamide—CALM3—Myometrial Relaxation and Contraction Pathways—NFKB1—abdominal aortic aneurysm	0.000686	0.00116	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.000684	0.00116	CbGpPWpGaD
Loperamide—POMC—Metabolism—PTGS2—abdominal aortic aneurysm	0.000683	0.00116	CbGpPWpGaD
Loperamide—CALM3—Platelet activation, signaling and aggregation—SERPINE1—abdominal aortic aneurysm	0.000681	0.00115	CbGpPWpGaD
Loperamide—OPRM1—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.000679	0.00115	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—NCF1—abdominal aortic aneurysm	0.000676	0.00115	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—NCF1—abdominal aortic aneurysm	0.000676	0.00115	CbGpPWpGaD
Loperamide—CALM1—Myometrial Relaxation and Contraction Pathways—NFKB1—abdominal aortic aneurysm	0.000663	0.00112	CbGpPWpGaD
Loperamide—CALM2—Myometrial Relaxation and Contraction Pathways—NFKB1—abdominal aortic aneurysm	0.000663	0.00112	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.000662	0.00112	CbGpPWpGaD
Loperamide—CALM2—Platelet activation, signaling and aggregation—SERPINE1—abdominal aortic aneurysm	0.000659	0.00112	CbGpPWpGaD
Loperamide—CALM1—Platelet activation, signaling and aggregation—SERPINE1—abdominal aortic aneurysm	0.000659	0.00112	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000654	0.00111	CbGpPWpGaD
Loperamide—ABCB1—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.000649	0.0011	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000638	0.00108	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.000634	0.00108	CbGpPWpGaD
Loperamide—OPRD1—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.000629	0.00107	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000624	0.00106	CbGpPWpGaD
Loperamide—CALM3—Immune System—SELL—abdominal aortic aneurysm	0.000621	0.00105	CbGpPWpGaD
Loperamide—CALM3—Fc epsilon receptor (FCERI) signaling—NFKB1—abdominal aortic aneurysm	0.000616	0.00104	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.000612	0.00104	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.000602	0.00102	CbGpPWpGaD
Loperamide—CALM1—Immune System—SELL—abdominal aortic aneurysm	0.000601	0.00102	CbGpPWpGaD
Loperamide—CALM2—Immune System—SELL—abdominal aortic aneurysm	0.000601	0.00102	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000597	0.00101	CbGpPWpGaD
Loperamide—CALM2—Fc epsilon receptor (FCERI) signaling—NFKB1—abdominal aortic aneurysm	0.000596	0.00101	CbGpPWpGaD
Loperamide—CALM1—Fc epsilon receptor (FCERI) signaling—NFKB1—abdominal aortic aneurysm	0.000596	0.00101	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.000592	0.001	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.000592	0.001	CbGpPWpGaD
Loperamide—CACNA1A—Metabolism—PTGS2—abdominal aortic aneurysm	0.00059	0.001	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000584	0.00099	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000571	0.000968	CbGpPWpGaD
Loperamide—CALM3—B Cell Activation—NFKB1—abdominal aortic aneurysm	0.000571	0.000967	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.00056	0.000949	CbGpPWpGaD
Loperamide—CALM2—B Cell Activation—NFKB1—abdominal aortic aneurysm	0.000552	0.000935	CbGpPWpGaD
Loperamide—CALM1—B Cell Activation—NFKB1—abdominal aortic aneurysm	0.000552	0.000935	CbGpPWpGaD
Loperamide—CALM3—Disease—LRP1—abdominal aortic aneurysm	0.000552	0.000935	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.000552	0.000935	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.000536	0.000909	CbGpPWpGaD
Loperamide—CALM2—Disease—LRP1—abdominal aortic aneurysm	0.000534	0.000905	CbGpPWpGaD
Loperamide—CALM1—Disease—LRP1—abdominal aortic aneurysm	0.000534	0.000905	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000524	0.000888	CbGpPWpGaD
Loperamide—CALM3—Immune System—AAAS—abdominal aortic aneurysm	0.000519	0.000879	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—abdominal aortic aneurysm	0.000507	0.000858	CbGpPWpGaD
Loperamide—CALM1—Immune System—AAAS—abdominal aortic aneurysm	0.000502	0.000851	CbGpPWpGaD
Loperamide—CALM2—Immune System—AAAS—abdominal aortic aneurysm	0.000502	0.000851	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000501	0.000849	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000501	0.000849	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000495	0.00084	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.00048	0.000813	CbGpPWpGaD
Loperamide—CALM3—Disease—AAAS—abdominal aortic aneurysm	0.000479	0.000812	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000473	0.000802	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.00047	0.000797	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.000466	0.00079	CbGpPWpGaD
Loperamide—CALM2—Disease—AAAS—abdominal aortic aneurysm	0.000463	0.000785	CbGpPWpGaD
Loperamide—CALM1—Disease—AAAS—abdominal aortic aneurysm	0.000463	0.000785	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000443	0.00075	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—abdominal aortic aneurysm	0.00044	0.000745	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000427	0.000724	CbGpPWpGaD
Loperamide—CALM3—Immune System—NCF1—abdominal aortic aneurysm	0.000424	0.000718	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000423	0.000717	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000421	0.000713	CbGpPWpGaD
Loperamide—CALM3—Signaling by NGF—NFKB1—abdominal aortic aneurysm	0.00042	0.000712	CbGpPWpGaD
Loperamide—CALM3—Disease—LDLR—abdominal aortic aneurysm	0.000418	0.000709	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—NOS2—abdominal aortic aneurysm	0.000417	0.000707	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000413	0.000699	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—AAAS—abdominal aortic aneurysm	0.000412	0.000699	CbGpPWpGaD
Loperamide—CALM2—Immune System—NCF1—abdominal aortic aneurysm	0.00041	0.000695	CbGpPWpGaD
Loperamide—CALM1—Immune System—NCF1—abdominal aortic aneurysm	0.00041	0.000695	CbGpPWpGaD
Loperamide—CALM1—Signaling by NGF—NFKB1—abdominal aortic aneurysm	0.000406	0.000689	CbGpPWpGaD
Loperamide—CALM2—Signaling by NGF—NFKB1—abdominal aortic aneurysm	0.000406	0.000689	CbGpPWpGaD
Loperamide—CALM2—Disease—LDLR—abdominal aortic aneurysm	0.000405	0.000686	CbGpPWpGaD
Loperamide—CALM1—Disease—LDLR—abdominal aortic aneurysm	0.000405	0.000686	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—NOS2—abdominal aortic aneurysm	0.000403	0.000684	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—NOS2—abdominal aortic aneurysm	0.000403	0.000684	CbGpPWpGaD
Loperamide—CALM3—Metabolism—AAAS—abdominal aortic aneurysm	0.000401	0.00068	CbGpPWpGaD
Loperamide—CALM3—Disease—NCF1—abdominal aortic aneurysm	0.000391	0.000663	CbGpPWpGaD
Loperamide—CALM1—Metabolism—AAAS—abdominal aortic aneurysm	0.000388	0.000658	CbGpPWpGaD
Loperamide—CALM2—Metabolism—AAAS—abdominal aortic aneurysm	0.000388	0.000658	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000386	0.000655	CbGpPWpGaD
Loperamide—CALM2—Disease—NCF1—abdominal aortic aneurysm	0.000378	0.000641	CbGpPWpGaD
Loperamide—CALM1—Disease—NCF1—abdominal aortic aneurysm	0.000378	0.000641	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000375	0.000635	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000374	0.000634	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000374	0.000634	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.000372	0.000631	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.000362	0.000613	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000362	0.000613	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.00036	0.000611	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.00036	0.000611	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—LDLR—abdominal aortic aneurysm	0.00036	0.00061	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000355	0.000602	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.000354	0.000601	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.000351	0.000595	CbGpPWpGaD
Loperamide—CALM3—Metabolism—LDLR—abdominal aortic aneurysm	0.00035	0.000594	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.00035	0.000593	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.00035	0.000593	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—AAAS—abdominal aortic aneurysm	0.000349	0.000592	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000349	0.000591	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.00034	0.000576	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.00034	0.000576	CbGpPWpGaD
Loperamide—CALM1—Metabolism—LDLR—abdominal aortic aneurysm	0.000339	0.000574	CbGpPWpGaD
Loperamide—CALM2—Metabolism—LDLR—abdominal aortic aneurysm	0.000339	0.000574	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000337	0.000572	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.000332	0.000563	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000331	0.00056	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.000321	0.000544	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.000321	0.000544	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000317	0.000537	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—LDLR—abdominal aortic aneurysm	0.000305	0.000516	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—AAAS—abdominal aortic aneurysm	0.000304	0.000515	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000296	0.000501	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000293	0.000496	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—APOE—abdominal aortic aneurysm	0.00029	0.000491	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—AAAS—abdominal aortic aneurysm	0.000287	0.000486	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000283	0.00048	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000283	0.00048	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000278	0.000471	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000274	0.000464	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—LDLR—abdominal aortic aneurysm	0.000265	0.00045	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000265	0.000449	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000265	0.000449	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000262	0.000444	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000259	0.00044	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000253	0.00043	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000253	0.00043	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—LDLR—abdominal aortic aneurysm	0.00025	0.000424	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—AGT—abdominal aortic aneurysm	0.00025	0.000424	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000245	0.000415	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000244	0.000413	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	0.000243	0.000411	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.00024	0.000406	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000232	0.000393	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000232	0.000393	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.00023	0.00039	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000228	0.000386	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.000223	0.000377	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.000223	0.000377	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.00022	0.000373	CbGpPWpGaD
Loperamide—CALM3—Disease—APOE—abdominal aortic aneurysm	0.000217	0.000367	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000216	0.000366	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000213	0.000361	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000213	0.000361	CbGpPWpGaD
Loperamide—CALM2—Disease—APOE—abdominal aortic aneurysm	0.00021	0.000355	CbGpPWpGaD
Loperamide—CALM1—Disease—APOE—abdominal aortic aneurysm	0.00021	0.000355	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000209	0.000354	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000209	0.000354	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000206	0.000349	CbGpPWpGaD
Loperamide—CALM3—Disease—NOS2—abdominal aortic aneurysm	0.000202	0.000342	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000199	0.000337	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000197	0.000333	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000196	0.000332	CbGpPWpGaD
Loperamide—CALM2—Disease—NOS2—abdominal aortic aneurysm	0.000195	0.000331	CbGpPWpGaD
Loperamide—CALM1—Disease—NOS2—abdominal aortic aneurysm	0.000195	0.000331	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000192	0.000326	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—AGT—abdominal aortic aneurysm	0.00019	0.000322	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.00019	0.000321	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.00019	0.000321	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—AAAS—abdominal aortic aneurysm	0.000187	0.000318	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—APOE—abdominal aortic aneurysm	0.000186	0.000316	CbGpPWpGaD
Loperamide—CALM3—Metabolism—AGT—abdominal aortic aneurysm	0.000185	0.000314	CbGpPWpGaD
Loperamide—CALM3—Metabolism—APOE—abdominal aortic aneurysm	0.000181	0.000307	CbGpPWpGaD
Loperamide—CALM2—Metabolism—AGT—abdominal aortic aneurysm	0.000179	0.000304	CbGpPWpGaD
Loperamide—CALM1—Metabolism—AGT—abdominal aortic aneurysm	0.000179	0.000304	CbGpPWpGaD
Loperamide—CALM2—Metabolism—APOE—abdominal aortic aneurysm	0.000175	0.000297	CbGpPWpGaD
Loperamide—CALM1—Metabolism—APOE—abdominal aortic aneurysm	0.000175	0.000297	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000174	0.000295	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000172	0.000292	CbGpPWpGaD
Loperamide—CALM3—Disease—SERPINE1—abdominal aortic aneurysm	0.00017	0.000288	CbGpPWpGaD
Loperamide—CALM2—Disease—SERPINE1—abdominal aortic aneurysm	0.000164	0.000279	CbGpPWpGaD
Loperamide—CALM1—Disease—SERPINE1—abdominal aortic aneurysm	0.000164	0.000279	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—LDLR—abdominal aortic aneurysm	0.000164	0.000277	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—AGT—abdominal aortic aneurysm	0.000161	0.000273	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—APOE—abdominal aortic aneurysm	0.000158	0.000267	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000155	0.000262	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000152	0.000257	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—AGT—abdominal aortic aneurysm	0.00015	0.000254	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—AGT—abdominal aortic aneurysm	0.00015	0.000254	CbGpPWpGaD
Loperamide—CALM3—Disease—PTGS2—abdominal aortic aneurysm	0.000148	0.000252	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000147	0.00025	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000147	0.000249	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000147	0.000249	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000146	0.000247	CbGpPWpGaD
Loperamide—CALM1—Disease—PTGS2—abdominal aortic aneurysm	0.000144	0.000243	CbGpPWpGaD
Loperamide—CALM2—Disease—PTGS2—abdominal aortic aneurysm	0.000144	0.000243	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—AGT—abdominal aortic aneurysm	0.00014	0.000238	CbGpPWpGaD
Loperamide—CALM3—Immune System—NFKB1—abdominal aortic aneurysm	0.00014	0.000236	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—APOE—abdominal aortic aneurysm	0.000137	0.000233	CbGpPWpGaD
Loperamide—CALM2—Immune System—NFKB1—abdominal aortic aneurysm	0.000135	0.000229	CbGpPWpGaD
Loperamide—CALM1—Immune System—NFKB1—abdominal aortic aneurysm	0.000135	0.000229	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—AGT—abdominal aortic aneurysm	0.000132	0.000224	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—APOE—abdominal aortic aneurysm	0.00013	0.00022	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—PTGS2—abdominal aortic aneurysm	0.000128	0.000216	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000127	0.000216	CbGpPWpGaD
Loperamide—CALM3—Metabolism—PTGS2—abdominal aortic aneurysm	0.000124	0.000211	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000123	0.000209	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000123	0.000209	CbGpPWpGaD
Loperamide—CALM2—Metabolism—PTGS2—abdominal aortic aneurysm	0.00012	0.000204	CbGpPWpGaD
Loperamide—CALM1—Metabolism—PTGS2—abdominal aortic aneurysm	0.00012	0.000204	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000119	0.000202	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000115	0.000195	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000115	0.000195	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PTGS2—abdominal aortic aneurysm	0.000108	0.000183	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PTGS2—abdominal aortic aneurysm	9.42e-05	0.00016	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MMP9—abdominal aortic aneurysm	9.12e-05	0.000155	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—NFKB1—abdominal aortic aneurysm	9.02e-05	0.000153	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PTGS2—abdominal aortic aneurysm	8.88e-05	0.00015	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MMP9—abdominal aortic aneurysm	8.82e-05	0.000149	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MMP9—abdominal aortic aneurysm	8.82e-05	0.000149	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	8.73e-05	0.000148	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—NFKB1—abdominal aortic aneurysm	8.73e-05	0.000148	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—AGT—abdominal aortic aneurysm	8.64e-05	0.000147	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—APOE—abdominal aortic aneurysm	8.47e-05	0.000144	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PTGS2—abdominal aortic aneurysm	5.8e-05	9.84e-05	CbGpPWpGaD
